Tylenol-maker shares hit after report RFK Jr will suggest autism link
4 days ago
- #Tylenol
- #Pregnancy
- #Autism
- Tylenol-maker Kenvue's shares dropped sharply after a report suggested a potential link between autism and Tylenol use during pregnancy.
- Kenvue defended its product, stating there is no causal link between acetaminophen use during pregnancy and autism.
- The US Department of Health and Human Services dismissed claims about the contents of its upcoming autism report as speculation.
- Robert F. Kennedy Jr. is expected to issue findings this month, citing Tylenol use during pregnancy as a potential cause of autism.
- Medical organizations, including the American College of Obstetricians and Gynecologists, recommend consulting doctors before using acetaminophen during pregnancy.
- Recent studies on acetaminophen's link to autism have been inconclusive, with some showing a potential risk and others finding no significant link.
- A 2024 study in the Journal of the American Medical Association found no evidence supporting a causal link between Tylenol and autism.
- Kenvue faces lawsuits alleging Tylenol causes autism, but a US judge dismissed federal cases due to lack of scientific evidence.